Previous strategies stop working
Murthy SN, Hilaire RC, Casey DB, Badejo AM, McGee J, McNamara DB, Kadowitz PJ, Fonseca VA: The synthetic GLP-I receptor agonist, exenatide, reduces intimal hyperplasia in insulin resistant rats
Despite this, people with type 2 diabetes tend to lose less weight on a GLP-1 than people who don't have the condition, and for reasons that aren't quite clear, says Silvana Obici, MD, chief of the division of endocrinology at Stony Brook Medicine and medical director of the Stony Brook University Hospital Diabetes Center in New York
Its important to consult a healthcare professional before starting any new supplement regimen
GLP-1RA-treated mice showed an enhanced response to insulin, as reflected by a more pronounced decline in blood glucose during the first 60 min post-injection compared to untreated db/db mice (Fig